← SynDRA
AROFYLLINE
SynDRA canonical compound SYN0025631 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
| Primary target(s) | PDE4A |
| Mechanism of action | Phosphodiesterase inhibitor |
All known targets
Mechanisms of action (all sources)
- Phosphodiesterase inhibitor
Cross-references
Synonyms
- Arofilina
- LAS-31025
- Arofyllin
- KM09088
- Arofylline (USAN/INN)
- 3-(4-chlorophenyl)-1-propyl-3,7-dihydro-1H-purine-2,6-dione
- 3-(4-chlorophenyl)-1-propyl-7H-purine-2,6-dione
- 3-(p-Chlorophenyl)-1-propylxanthine
- 1H-Purine-2,6-dione,3-(4-chlorophenyl)-3,9-dihydro-1-propyl-
- Arofylline [USAN:INN:BAN]
- UNII-87L38AY71R
- 1-n-propyl-3-(4-chlorophenyl)-xanthine
- AROFYLLINE [INN]
- AROFYLLINE [USAN]
- MLS000860828
- SCHEMBL119420
- orb1297862
- GVTLDPJNRVMCAL-UHFFFAOYSA-N
- GLXC-25207
- HMS2799J08
- CCG-246350
- NCGC00246682-01
- DA-50711
- SMR000459612
- TS-10058
- HY-105096
- CS-0024978
- NS00016656
- T9816
- D02985
- BRD-K33852358-001-06-5
- BRD-K33852358-001-09-9
Look up AROFYLLINE in the interactive SynDRA portal →